Related Experiment Video
Updated: Jun 29, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
India marching towards TB elimination: How far we are
Payel Roy1, Ambarish Das1, Ashutosh Panda1
1Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
India faces significant challenges in eliminating tuberculosis (TB), despite its potential. Addressing issues like budget, diagnostics, and social stigma is crucial for the National Tuberculosis Elimination Program (NTEP) to succeed.
Area of Science:
- Public Health
- Infectious Diseases Epidemiology
- Global Health Security
Background:
- Tuberculosis (TB) remains a primary global cause of mortality.
- India accounts for 25% of the global TB burden.
- The National Tuberculosis Elimination Program (NTEP) aims to eradicate TB by 2025.
Purpose of the Study:
- To outline the challenges hindering TB elimination in India.
- To propose strategies for strengthening TB control programs.
- To assess India's potential for achieving TB-free status.
Main Methods:
- Review of existing TB control strategies in India.
- Analysis of programmatic challenges and their impact.
- Identification of key areas for program strengthening.
Main Results:
- Key challenges include insufficient funding, inadequate diagnostics, under-reporting, low treatment success, high dropout rates, and social stigma.
- Swift action is needed for case identification, notification, and treatment.
- Programmatic strengthening is essential for TB elimination.
Conclusions:
- India possesses the potential to eliminate TB.
- Strengthening the health system, integrating private sector efforts, and enhancing diagnostic capabilities are vital.
- Addressing social barriers and advocating for increased budgets are critical measures for achieving a TB-free India.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

